Clinical Study of Abhaya And Ashwagandha Granules In the Management Of Generalized Anxiety Disorder
Phase 2
- Conditions
- Health Condition 1: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2023/05/052886
- Lead Sponsor
- ATIONAL INSTITUTE OF AYURVEDA JAIPUR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of either sex between the age of 20â??60 years, fulfilling DSM V diagnostic criteria for Generalized Anxiety Disorder (GAD) will be included in the study.
Exclusion Criteria
1.Patients taking medication for stress disorder,
2.Patients with symptoms of Unmad(co-morbid psychiatric disorders); on psychotropic drugs four weeks prior to study; substance abuse like alcohol etc.; significant depression (BDI >17);
3.Other medical complications like uncontrolled hypertension, diabetes mellitus;
•Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢Change in Hamiltonâ??s Anxiety Rating Scale.Timepoint: 28 Days
- Secondary Outcome Measures
Name Time Method â?¢Change in Pittsburgh Sleep Quality Index (PSQI) <br/ ><br>â?¢Change in WHO Quality of Life- BREF (WHOQOL-BREF) <br/ ><br>â?¢Change in Clinical Global Improvement scale (CGI) <br/ ><br>â?¢Change in Serum Cortisol level <br/ ><br>Timepoint: 28 Days